摘要
| 原文 | English |
|---|---|
| 專利號 | 8377902 |
| 出版狀態 | Published - 2011 七月 7 |
指紋
引用此文
}
RNAi compound targeted to thrombospondin-1 and applications thereof. / Lai, Ming-Derg (Inventor).
專利號: 8377902.研究成果: Patent
TY - PAT
T1 - RNAi compound targeted to thrombospondin-1 and applications thereof
AU - Lai, Ming-Derg
PY - 2011/7/7
Y1 - 2011/7/7
N2 - The present invention relates to an RNAi compound and an expression plasmid for inhibiting expression of Thrombospondin-1, which comprises a target sequence selected from Thrombospondin-1 gene. The present invention also related to a pharmaceutical composition comprising the RNAi compound and applications thereof. The RNAi compound can reduce the expression of Thrombospondin-1 to activate immune responses.
AB - The present invention relates to an RNAi compound and an expression plasmid for inhibiting expression of Thrombospondin-1, which comprises a target sequence selected from Thrombospondin-1 gene. The present invention also related to a pharmaceutical composition comprising the RNAi compound and applications thereof. The RNAi compound can reduce the expression of Thrombospondin-1 to activate immune responses.
M3 - Patent
M1 - 8377902
ER -